Analyst Research Report Snapshot

Title:

中美晶 (5483 TT, NT$42.25, 增加持股): 調評等由「持有」調升至「增加持股」

Price:

$46.00

Provider:

KGI Greater China

Date:

11 Nov 2013

Pages:

6

Type:

AcrobatPDF

Companies referenced:

5483.TWO

Available for Immediate Download
Summary:

中期復甦符合預期 第三季每股盈餘0.10元,受惠於毛利率季增1.9個百分點至14.1%,高於凱基預估的損益兩平 併購效益和太陽能產業展望改善帶動中期獲利復甦;2014年每股盈餘預估上修至1.81元 評等由「持有」調升為「增加持股」;12個月目標價自37.6元上修為50元,為2014年平均每股淨值預估38.5元1.3倍,上漲空間18.3% 公司目前股價為我們2014年每股淨值預估38.5元1.1倍,居於五年股價淨值比區間0.7-2.9倍低緣。考量基本面復甦,我們將目標股價淨值比自1.0倍上修為1.3倍。12個月目標價自37.6元上修為50元,相當於我們2014年每股淨值預估平均38.5元的1.3倍,上漲空間18.3%。我們上調評等由「持有」至「增加持股」,建議投資人於淡季加碼。

Why buy analyst research?

  • Institutional quality research
  • Available for Immediate Download
  • Detailed company or industry insight
  • Print or save
  • 24 hour customer support
Return to previous page without adding this item to your cart.
Email Customer Support.

About Analyst Research

Analyst research reports are available for immediate download after purchase. You will have unlimited access to the report for 24 hours after purchase, to download, print or save it as many times as you wish. Analyst Research provided by Reuters does not constitute investment advice, and is not endorsed by Reuters Research. This information is protected by copyright and intellectual property laws. More information on Analyst Research.